Environmental Endocrine Disruptors and High-Risk Cardiometabolic Phenotypes: A Systematic Review and Meta-Analysis of Epidemiological Evidence Linking Exposure to Bisphenol A, Phthalates, PFAS, PCBs, and Other EDCs with Cardiometabolic Outcomes and C
General Medicine and Clinical Practice · 07.05.2026 · 09 (06) · 01-07
DOI: 10.31579/2639-4162/355 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift General Medicine and Clinical Practice, online erschienen am 07.05.2026. Verfasst von Camilo Fernández Bravo.
Abstract (Originalsprache)
Background
Endocrine-disrupting chemicals (EDCs) are ubiquitous environmental contaminants that interfere with hormonal signaling pathways, potentially contributing to the rising global burden of cardiometabolic diseases. Common EDCs include bisphenol A (BPA), phthalates, per- and polyfluoroalkyl substances (PFAS), polychlorinated biphenyls (PCBs), and organochlorine pesticides. These compounds have been implicated in promoting high-risk cardiometabolic phenotypes such as obesity, insulin resistance (IR), type [2] diabetes mellitus (T2DM), dyslipidemia, hypertension, and metabolic syndrome (MetS), which collectively accelerate atherosclerosis and cardiovascular disease (CVD). Despite growing evidence, comprehensive syntheses across EDC classes and life stages remain limited.
Objective
This systematic review and meta-analysis aims to evaluate the associations between EDC exposure and cardiometabolic phenotypes/CVD outcomes, with a focus on mechanistic pathways including epigenetics, oxidative stress, IR, and subclinical inflammation Methods: Following PRISMA guidelines, we searched PubMed, Embase, Web of Science, and Scopus from inception to February 2026 for observational studies (cohort, cross-sectional, case-control) and prior meta-analyses reporting odds ratios (ORs), relative risks (RRs), or hazard ratios (HRs) for EDC exposure and outcomes. Inclusion criteria: human studies with quantitative exposure biomarkers (e.g., urinary/serum levels) and cardiometabolic/CVD endpoints. Exclusion: animal/in vitro studies, non-relevant outcomes. Data extraction included EDC type, exposure timing (prenatal/adult), sample size, adjustments, and effect sizes. Quality was assessed via Newcastle-Ottawa Scale (NOS) for primary studies and AMSTAR-2 for meta-analyses. Random-effects models pooled estimates; heterogeneity via I²; subgroups by EDC class, sex, age, and exposure window. Publication bias: Egger’s test/funnel plots. Analyses performed in R (meta package).
Results
From 1,256 screened articles, 58 were included (total n>500,000 across studies), encompassing 29 primary studies and 29 meta-analyses/syntheses. Pooled ORs (95% CI) for CVD morbidity: BPA 1.19 (1.03–1.37; I²=62%); phthalates 1.11 (1.06–1.17; I²=55%); PCBs (e.g., PCB138/153) 1.35 (1.10–1.66; I²=68%); organochlorine pesticides 1.12 (1.00–1.24; I²=50%); PFAS (e.g., PFOA/PFOS) 1.15 (1.05–1.26; I²=72%). For cardiometabolic phenotypes: BPA with T2DM OR 1.28 (1.12–1.46); phthalates with IR (HOMA-IR MD 0.71, 0.45–0.97); PFAS with hypertension OR 1.21 (1.07–1.38). Prenatal exposures showed stronger associations (e.g., maternal BPA with offspring obesity OR 1.45, 1.20–1.75). Heterogeneity was moderate-high, partly explained by exposure mixtures and developmental timing. No significant publication bias (Egger’s p>0.05). Mechanistic evidence supports EDC-induced epigenetic reprogramming (e.g., DNA methylation of PPARγ), oxidative stress (↑ROS/MDA), IR (↓IRS-1/Akt), and inflammation (↑TNF-α/IL-6).
Conclusions
EDC exposure is consistently associated with elevated risks of high-risk cardiometabolic phenotypes and CVD, particularly via early-life exposures and synergistic mechanisms. These findings underscore the need for regulatory interventions to reduce exposure and integrate EDC biomonitoring into CVD prevention strategies. Future research should prioritize longitudinal multi-omics studies on mixtures and transgenerational effects.
Zitieren
APA
Bravo, C. F. (2026). Environmental Endocrine Disruptors and High-Risk Cardiometabolic Phenotypes: A Systematic Review and Meta-Analysis of Epidemiological Evidence Linking Exposure to Bisphenol A, Phthalates, PFAS, PCBs, and Other EDCs with Cardiometabolic Outcomes and C. General Medicine and Clinical Practice, 09(06), 01-07. https://doi.org/10.31579/2639-4162/355
Vancouver
Bravo CF. Environmental Endocrine Disruptors and High-Risk Cardiometabolic Phenotypes: A Systematic Review and Meta-Analysis of Epidemiological Evidence Linking Exposure to Bisphenol A, Phthalates, PFAS, PCBs, and Other EDCs with Cardiometabolic Outcomes and C. General Medicine and Clinical Practice. 2026;09(06):01-07. doi:10.31579/2639-4162/355
BibTeX
@article{Bravo2026,
author = {Bravo, Camilo Fernández},
title = {Environmental Endocrine Disruptors and High-Risk Cardiometabolic Phenotypes: A Systematic Review and Meta-Analysis of Epidemiological Evidence Linking Exposure to Bisphenol A, Phthalates, PFAS, PCBs, and Other EDCs with Cardiometabolic Outcomes and C},
journal = {General Medicine and Clinical Practice},
year = {2026},
volume = {09},
number = {06},
pages = {01--07},
doi = {10.31579/2639-4162/355}
}
EUVIMED